The Global Artificial Intelligence (AI) In Genomics Market Growth Accelerated By Increased Adoption Of AI-Powered Precision Medicine
![]() |
Artificial Intelligence (AI) In Genomics Market |
Artificial intelligence (AI) has the potential to address
key challenges in genomics by leveraging vast amounts of complex health data.
AI applications such as machine learning and deep learning are being used for
analyzing genomes, developing risk assessments and predictive models for
certain diseases. AI is also helping in personalized disease diagnosis and
treatment through precision medicine approaches.
The global Artificial Intelligence (AI) in Genomics Market
is estimated to be valued at US$ 1.2 Billion in 2023 and is expected to exhibit
a CAGR of 6.1% over the forecast
period 2023 to 2030, as highlighted in a new report published by Coherent
Market Insights.
Market key trends: Increased
adoption of AI-powered precision medicine is one of the key trends driving the
growth of the AI in Genomics market. Precision medicine is an emerging approach
for disease treatment and prevention that takes into account individual
variability in genetics, environment, and lifestyle for each person. AI algorithms
can analyze complex genomic and other health-related data to identify genomic
variations specific to an individual that affect disease risk, and help develop
customized treatment and prevention strategies. This is expected to
significantly improve treatment outcomes. AI is also helping in developing
effective targeted therapies and personalized treatment regimens. The
increasing demand for these precision medicine approaches is expected to boost
the adoption of AI solutions in genomics, thereby propelling the market growth
over the forecast period.
Segment Analysis
The global Artificial Intelligence (AI) in Genomics Market can be segmented
based on offering, technology, application, end-use industry and region. In
terms of offering, the services segment dominated the market in 2022 due to the
growing demand for AI-driven precision medicine. Organizations are widely
adopting various AI-enabled genomics services to modernize healthcare
infrastructure and offer personalized treatment to patients.
Key Takeaways
The global
Artificial Intelligence (AI) in Genomics market analysis is expected to
witness high growth over the forecast period of 2023 to 2030. The global
Artificial Intelligence (AI) in Genomics Market is estimated to be valued at
US$ 1.2 Billion in 2023 and is expected to exhibit a CAGR of 6.1% over the
forecast period 2023 to 2030.
Regional analysis related content comprises: North America
dominated the global market in 2022 due to heavy investments by leading AI and
genomics companies as well as research institutes in countries like the United
States and Canada. Growing adoption of precision medicine and rapidly
increasing genomics research initiatives have further accelerated the regional
market growth.
Key players related content comprises: Key players operating in the Artificial
Intelligence (AI) in Genomics market are IBM, Microsoft, NVIDIA Corporation,
Deep Genomics, BenevolentAI, Fabric Genomics, Inc., MolecularMatch, Inc.,
Cambridge Cancer Genomics, Freenome Holdings, Inc., Data4Cure, Inc., PrecisionLife
Ltd, Lifebit Biotech, Ltd, Anthropic, and Tempus Labs, Inc.
Get more insights on this topic: https://www.newswirestats.com/artificial-intelligence-ai-in-genomics-market-industry-insights-trends-artificial-intelligence-ai-in-genomics-market/
Explore
more information on this topic, Please visit: https://masstamilan.in/pulse-precision-navigating-the-future-through-the-intricacies-of-distributed-fiber/
Comments
Post a Comment